Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sulodexide

Sulodexide is a mixture of glycosaminoglycans available in soft capsule form for oral administration. It is composed of low molecular weight heparin (80%) and dermatan sulfate (20%) . Sulodexide exhibits antithrombotic activity through interaction with antithrombin III (AT III) and heparin cofactor II (HC II), and inhibition of thrombin formation. Sulodexide exhibits profibrinolytic activity through release of tissue plasminogen activator (tPA) . Sulodexide exhibits endothelial protective and anti-inflammatory effect, ameliorates chronic venous disease[1]. Sulodexide is a glycosaminoglycan mixture available in soft gelatin capsule form for oral administration.

Product Specifications

CAS Number

57821-29-1

UNSPSC

12352100

Target

Thrombin

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/sulodexide.html

Purity

0

Solubility

DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

[Sulodexide]

References & Citations

[1]Andreozzi GM. Sulodexide in the treatment of chronic venous disease. Am J Cardiovasc Drugs. 2012 Apr 1;12 (2) :73-81. |[2]Yung S, et al. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy[J]. PloS one, 2013, 8 (1) : e54501.|[3]Jo H, et al. Sulodexide inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy[J]. BMB reports, 2014, 47 (11) : 637.|[4]Huang R, et al. Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell[J]. Biomedicine & Pharmacotherapy, 2023, 160: 114396.|[5]Ying J, et al. Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis[J]. Frontiers in immunology, 2023, 14: 1172892.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 4

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

C5orf40 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
LV812265 1.0 µg DNA

C5orf40 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

Sign In for Pricing
View Details
CAPN9 Antibody
E034521 100 µg -100 µL

CAPN9 Antibody

Sign In for Pricing
View Details
N-Methyl- (2-methyl-1,3-oxazol-4-yl) methylamine
Fr14600-01 100 mg

N-Methyl- (2-methyl-1,3-oxazol-4-yl) methylamine

Sign In for Pricing
View Details
N-Methyl- (2-methyl-1,3-oxazol-4-yl) methylamine
Fr14600-02 2 mg

N-Methyl- (2-methyl-1,3-oxazol-4-yl) methylamine

Sign In for Pricing
View Details
N-Methyl- (2-methyl-1,3-oxazol-4-yl) methylamine
Fr14600-03 10 mg

N-Methyl- (2-methyl-1,3-oxazol-4-yl) methylamine

Sign In for Pricing
View Details
MRPS14 293 Cell Lysate
402528 0.1 mg

MRPS14 293 Cell Lysate

Sign In for Pricing
View Details